Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Liu Yang
Institutions:
Zhejiang Provincial People's Hospital,
Hangzhou Medical College,
Nanjing Medical University
Observed institutions:
Chinese Academy of Sciences,
Shanghai Institute of Materia Medica,
Zhejiang Provincial People's Hospital,
University of Chinese Academy of Sciences,
Hangzhou Medical College,
State Key Laboratory of Drug Research,
Nanjing Medical University
show all 7
ORCID:
0009-0008-8401-3250
Observed ORCID:
0009-0008-8401-3250
OpenAlex ID:
A5134515494
Downregulation of ubiquitous microRNA-320 in hepatocytes triggers RFX1-mediated FGF1 suppression to accelerate MASH progression
2025
·
Liu Yang
, Wenjun Li
, et al.
·
Acta Pharmaceutica Sinica B
·
5
ANXA1-FPR1 signaling in myeloid cells drives MASH by elevating S100A4/A11
2026
·
Siting Yang
, Shengying Qian
, et al.
·
JHEP Reports
·
3
PDF
Interleukin-19 ameliorates drug-induced liver injury by limiting proinflammatory macrophage infiltration via SUMOylation of C/EBPβ
2026
·
Peng Xiao
, Qiuhong Zai
, et al.
·
Journal of Hepatology
·
1
Retraction: microRNA526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma
2026
·
Xin Liu
, Liu Yang
, et al.
·
Oncotarget
PDF
Show more works
View as search
Works count:
4
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type